Conquering Diseases

Anticoagulant Study For Patients With Atrial Fibrillation After Aortic Valve Implantation

Description

Seeking men and women 18 years and older who have undergone a successful replacement of narrowed aortic valve and require treatment with oral blood thinners.

Overview

We are studying the effect of an new/investigational anticoagulant drug versus the standard treatment. The treatments will be compared for safety with regards to bleeding.

What we're hoping for

Evaluate the safety and effectiveness of the investigational drug in patients with atrial fibrillation following aortic valve implantation (TAVI).

Additional Information

ClinicalTrials.gov Identifier: NCT02943785

 Principal Investigator

Nikolaos  Kakouros, MD

UMass Memorial Health

 Study Contact

Cardiovascular Research Office

(508) 856-1014

CardioResearch@umassmed.edu

 Location

UMass Chan University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989